위식도역류질환 치료 시장 : 제품 유형, 시술 유형, 수술 유형, 기기 유형, 제형, 투여 경로, 최종 사용자별 - 세계 예측(2025-2030년)

The Gastroesophageal Reflux Disease Devices Market was valued at USD 5.85 billion in 2023, expected to reach USD 6.65 billion in 2024, and is projected to grow at a CAGR of 13.66%, to USD 14.35 billion by 2030.

The Gastroesophageal Reflux Disease (GERD) Devices market encompasses a range of medical devices aimed at diagnosing and treating GERD, a condition characterized by the backflow of stomach acid into the esophagus causing symptoms like heartburn and acid reflux. The necessity of these devices lies in the increasing prevalence of GERD, driven by factors such as lifestyle changes, obesity, and dietary habits. Their application extends across diagnostic endoscopy, pH monitoring for acid exposure, magnetic sphincter augmentation, and radiofrequency ablation, addressing patient needs from mild to severe reflux symptoms. End-use segments include hospitals, ambulatory surgical centers, and specialty clinics where the demand for minimally invasive solutions is rising. Key growth factors include advancements in endoscopic procedures, increased awareness of GERD complications, and supportive healthcare policies favoring device adoption. Market opportunities are expanding with technological innovations in device precision and patient comfort, and geographic expansion in emerging markets with rising healthcare infrastructure. To capture these opportunities, companies should focus on R&D in non-invasive diagnostics and treatment methods, customized device designs, and strategic partnerships to widen global outreach. However, the market faces limitations due to high costs of advanced devices, stringent regulatory approvals, and the availability of alternative treatment methods like medication and lifestyle modification, which might inhibit device adoption. Innovation could be directed towards developing cost-effective, patient-friendly diagnostic tools and exploring AI and machine learning for GERD monitoring solutions. The market is competitive with players focusing on product differentiation and patient outcomes, making it crucial for companies to continuously innovate and align with healthcare provider needs. Developing educational initiatives around GERD management could enhance end-user awareness and drive market penetration, fostering overall growth in the GERD devices sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gastroesophageal Reflux Disease Devices Market

The Gastroesophageal Reflux Disease Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising aging population across the world
  • Growing obese population and their preference for surgeries
  • Surge in adoption among diagnostic centers and private clinics
• Market Restraints
  • Availability of alternative such as proton pump inhibitors
• Market Opportunities
  • Robust innovation and launch of new advanced products in the market
  • Ongoing trend of self-medication and awareness of the disease
• Market Challenges
  • Decreased acceptability of devices an dearth of standard regulatory approval

Porter's Five Forces: A Strategic Tool for Navigating the Gastroesophageal Reflux Disease Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gastroesophageal Reflux Disease Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gastroesophageal Reflux Disease Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gastroesophageal Reflux Disease Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gastroesophageal Reflux Disease Devices Market

A detailed market share analysis in the Gastroesophageal Reflux Disease Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gastroesophageal Reflux Disease Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gastroesophageal Reflux Disease Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gastroesophageal Reflux Disease Devices Market

A strategic analysis of the Gastroesophageal Reflux Disease Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gastroesophageal Reflux Disease Devices Market, highlighting leading vendors and their innovative profiles. These include Addex Pharmaceuticals Ltd., Aros Pharma ApS, AstraZeneca PLC, C. R. Bard, Inc., Eisai Co., Ltd., EndoGastric Solutions, Inc., Frost & Sullivan Inc., Johnson & Johnson Services, Inc., KARL STORZ SE & Co. KG, MediGus Ltd., Olympus Corporation, PENTAX Europe GmbH, Pfizer Inc., Takeda Pharmaceutical Company Limited, and The Procter & Gamble Company.

Market Segmentation & Coverage

This research report categorizes the Gastroesophageal Reflux Disease Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product Type, market is studied across Diagnostic Devices, Esophagoscopes & Gastroscopes, Fundoplication Devices, Manometry System, PH Monitoring System, Radiofrequency Ablation Devices, Sphincter Augmentation Devices, Treatment Devices, and Ultrasonic Surgical Endostapler.
• Based on Procedure Type, market is studied across Diagnostic Procedures, Fundoplication Procedures, Magnetic Sphincter Augmentation, and Radiofrequency Thermal Ablation.
• Based on Surgery Type, market is studied across Invasive and Non-Invasive. The Invasive is further studied across Linx Reflux Management and Medigus Ultrasonic Surgical Endostapler. The Non-Invasive is further studied across Endocinch Endolumminal Gastroplication, Endoscopic Plicator System, EsophyX, Plexiglas Poly-Methyl-Methacrylate Microspheres, and Stretta.
• Based on Device Type, market is studied across Bravo Reflux Testing System, Digitrapper reflux testing system, LINX Management System, MUSE -Medigus Ultrasonic Surgical Endostapler, and Stretta Therapy.
• Based on Dosage Form, market is studied across Liquid and Solid.
• Based on Route of Administration, market is studied across Oral and Parenteral.
• Based on End-User, market is studied across Government, Hospitals, and Medical Practitioners.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising aging population across the world
    • 5.1.1.2. Growing obese population and their preference for surgeries
    • 5.1.1.3. Surge in adoption among diagnostic centers and private clinics
  • 5.1.2. Restraints
    • 5.1.2.1. Availability of alternative such as proton pump inhibitors
  • 5.1.3. Opportunities
    • 5.1.3.1. Robust innovation and launch of new advanced products in the market
    • 5.1.3.2. Ongoing trend of self-medication and awareness of the disease
  • 5.1.4. Challenges
    • 5.1.4.1. Decreased acceptability of devices an dearth of standard regulatory approval
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Gastroesophageal Reflux Disease Devices Market, by Product Type

• 6.1. Introduction
• 6.2. Diagnostic Devices
• 6.3. Esophagoscopes & Gastroscopes
• 6.4. Fundoplication Devices
• 6.5. Manometry System
• 6.6. PH Monitoring System
• 6.7. Radiofrequency Ablation Devices
• 6.8. Sphincter Augmentation Devices
• 6.9. Treatment Devices
• 6.10. Ultrasonic Surgical Endostapler

7. Gastroesophageal Reflux Disease Devices Market, by Procedure Type

• 7.1. Introduction
• 7.2. Diagnostic Procedures
• 7.3. Fundoplication Procedures
• 7.4. Magnetic Sphincter Augmentation
• 7.5. Radiofrequency Thermal Ablation

8. Gastroesophageal Reflux Disease Devices Market, by Surgery Type

• 8.1. Introduction
• 8.2. Invasive
  • 8.2.1. Linx Reflux Management
  • 8.2.2. Medigus Ultrasonic Surgical Endostapler
• 8.3. Non-Invasive
  • 8.3.1. Endocinch Endolumminal Gastroplication
  • 8.3.2. Endoscopic Plicator System
  • 8.3.3. EsophyX
  • 8.3.4. Plexiglas Poly-Methyl-Methacrylate Microspheres
  • 8.3.5. Stretta

9. Gastroesophageal Reflux Disease Devices Market, by Device Type

• 9.1. Introduction
• 9.2. Bravo Reflux Testing System
• 9.3. Digitrapper reflux testing system
• 9.4. LINX Management System
• 9.5. MUSE -Medigus Ultrasonic Surgical Endostapler
• 9.6. Stretta Therapy

10. Gastroesophageal Reflux Disease Devices Market, by Dosage Form

• 10.1. Introduction
• 10.2. Liquid
• 10.3. Solid

11. Gastroesophageal Reflux Disease Devices Market, by Route of Administration

• 11.1. Introduction
• 11.2. Oral
• 11.3. Parenteral

12. Gastroesophageal Reflux Disease Devices Market, by End-User

• 12.1. Introduction
• 12.2. Government
• 12.3. Hospitals
• 12.4. Medical Practitioners

13. Americas Gastroesophageal Reflux Disease Devices Market

• 13.1. Introduction
• 13.2. Argentina
• 13.3. Brazil
• 13.4. Canada
• 13.5. Mexico
• 13.6. United States

14. Asia-Pacific Gastroesophageal Reflux Disease Devices Market

• 14.1. Introduction
• 14.2. Australia
• 14.3. China
• 14.4. India
• 14.5. Indonesia
• 14.6. Japan
• 14.7. Malaysia
• 14.8. Philippines
• 14.9. Singapore
• 14.10. South Korea
• 14.11. Taiwan
• 14.12. Thailand
• 14.13. Vietnam

15. Europe, Middle East & Africa Gastroesophageal Reflux Disease Devices Market

• 15.1. Introduction
• 15.2. Denmark
• 15.3. Egypt
• 15.4. Finland
• 15.5. France
• 15.6. Germany
• 15.7. Israel
• 15.8. Italy
• 15.9. Netherlands
• 15.10. Nigeria
• 15.11. Norway
• 15.12. Poland
• 15.13. Qatar
• 15.14. Russia
• 15.15. Saudi Arabia
• 15.16. South Africa
• 15.17. Spain
• 15.18. Sweden
• 15.19. Switzerland
• 15.20. Turkey
• 15.21. United Arab Emirates
• 15.22. United Kingdom

16. Competitive Landscape

• 16.1. Market Share Analysis, 2023
• 16.2. FPNV Positioning Matrix, 2023
• 16.3. Competitive Scenario Analysis
• 16.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Addex Pharmaceuticals Ltd.
• 2. Aros Pharma ApS
• 3. AstraZeneca PLC
• 4. C. R. Bard, Inc.
• 5. Eisai Co., Ltd.
• 6. EndoGastric Solutions, Inc.
• 7. Frost & Sullivan Inc.
• 8. Johnson & Johnson Services, Inc.
• 9. KARL STORZ SE & Co. KG
• 10. MediGus Ltd.
• 11. Olympus Corporation
• 12. PENTAX Europe GmbH
• 13. Pfizer Inc.
• 14. Takeda Pharmaceutical Company Limited
• 15. The Procter & Gamble Company